Jul 14, 2025, 12:32
Anticoagulation in Liver Transplant Candidates: Is Apixaban Safe?
The American Journal of Transplantation shared a post on X:
”Up to 26% of liver transplant candidates have an indication for anticoagulation whilst on the waiting list. Apixaban appears safe to use in the peri-transplant setting for low MELD patients awaiting liver transplantation.”
Title: Safety of apixaban prior to liver transplantation: A single-center Australian case-control study in a population with low scores on the model for end-stage liver disease
Authors: Katrina Tan, Zoe Yang, Elizabeth Low, Jordi Shahab, Jacqueline Balassone, Graham Starkey, Marcos Perini, Lachlan Miles, Adam Testro, Marie Sinclair, Avik Majumdar
Read the full article here.
Stay informed with Hemostasis Today.
-
Aug 27, 2026, 13:21Precious Cosmas: Sonographic Features and Practical Approach to Deep Vein Thrombosis Assessment
-
Aug 27, 2026, 13:20Mital Jhaveri: Anticoagulation in Advanced CKD – Why Individualized Decisions Matter
-
Aug 27, 2026, 13:15Praveen Kaudlay: Advancing Hemophilia Care in Davanagere
-
Aug 27, 2026, 13:13Wolfgang Miesbach: Potential Transmission of Haemorrhagic Risk Through Blood Transfusion
-
Aug 27, 2026, 13:09Jignesh Patel: Can Edoxaban and Rivaroxaban Be Prescribed for Breastfeeding Mothers?
-
Aug 27, 2026, 13:09Nouran Abu-Obaid: Anticoagulation for New-Onset Atrial Fibrillation in Critical Illness
-
Aug 27, 2026, 13:04Nabil Chakfe: Carotid Stent Design and Antiplatelet Therapy Influence Thrombosis Risk
-
Aug 27, 2026, 13:01Lukong Hubert Shalanyuy: New Research on Thromboplastin Reagents and PT/INR Reliability
-
Aug 27, 2026, 11:08Sunisha Arora: New EBMT Recommendations Transform the Approach to HSCT in Thalassemia